Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies-Reference-Cited by-同舟云学术

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies

Published:2022-01-19 Issue:1 Volume:60 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Hiebert Joanne¹,Zubach Vanessa¹,Charlton Carmen L.²³⁴,Fenton Jayne²,Tipples Graham A.²⁴⁵,Fonseca Kevin²⁶,Severini Alberto¹⁷^ORCID

Affiliation:

1. Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

2. Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada

3. Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada

4. Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

5. Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada

6. Department of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, Alberta, Canada

7. Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract

Rubella and congenital rubella syndrome are caused by the rubella virus and are preventable through vaccination, making disease eradication possible. Monitoring of progress toward global eradication and local elimination requires high-quality, sensitive disease surveillance that includes laboratory confirmation of cases.

Funder

Public Health Agency of Canada

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01597-21

Reference23 articles.

1. Feasibility assessment of measles and rubella eradication

2. Public Health Agency of Canada. 2013. Elimination of measles rubella and congenital rubella syndrome in Canada: Documentation and verification report. Public Health Agency of Canada https://www.canada.ca/en/public-health/services/immunization/vaccine-preventable-diseases/elimination-measles-rubella-congenital-rubella-syndrome-canada-documentation-verification-report.html. Accessed 17 November 2020.

3. World Health Organization. 2013. Framework for verifying elimination of measles and rubella. Wkly Epidemiol Rec 88:89–99. https://www.who.int/publications/i/item/framework-for-verifying-elimination-of-measles-and-rubella.

4. World Health Organization. 2017. Roadmap to elimination standard measles and rubella surveillance. Wkly Epidemiol Rec 92:97–105. https://apps.who.int/iris/bitstream/handle/10665/254754/WER9209_10-97-105.pdf.

5. Dilemmas and Pitfalls in Rubella Laboratory Diagnostics in Low Prevalence or Elimination Settings

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of commercially available serological tests for the detection of measles and rubella viruses: a systematic review and meta-analysis;Journal of Clinical Microbiology;2024-02-14

2. Dimeric immunoglobulin A as a novel diagnostic marker of measles infection;Microbiology Spectrum;2024-01-11

3. Performance Characteristics of Six Immunoglobulin M Enzyme-Linked Immunosorbent Assays Used for Laboratory Confirmation of Measles;Journal of Clinical Microbiology;2022-12-21

4. Performance Characteristics of Six Immunoglobulin M (IgM) ELISA Assays Used for Laboratory Confirmation of Measles;2022-09-04